Chemical genetic analysis reveals the effects of NMU2R on the expression of peptide hormones

Neuroscience Letters

Volumn 404, Issue 1-2, 2006, Pages 148-153

  Fang, Liyan ^a   Zhang, Mancang ^a   Li, Chunxia ^a   Dong, Suzhen ^a   Hu, Yinghe ^a  

^a B326 Science Building   (China)

Author keywords

Agonist; EUK2010; Neuromedin U 2 receptor (NMU2R); Neuropeptide

Indexed keywords

EUK 2010; EUK 2011; EUK 2012; LEPTIN; NATURAL PRODUCT; NEUROMEDIN U; NEUROPEPTIDE RECEPTOR; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL GENETICS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SCREENING; EMBRYO; EXPERIMENTAL MODEL; FOOD INTAKE; GENE ACTIVATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HYPOTHALAMUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; REPORTER GENE; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ANIMALS; BODY WEIGHT; DNA PRIMERS; ENERGY INTAKE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LITHIUM CHLORIDE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PEPTIDE HORMONES; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTRANSMITTER;

EID: 33745984868     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.05.034     Document Type: Article

References (33)

1. Abiko T., and Takamura Y. Synthesis of two neuromedin u (nmu) analogues and their comparative effect of reducing food intake in rats. Prep. Biochem. Biotechnol. 32 (2002) 79-86
2. Benoit S.C., Schwartz M.W., Lachey J.L., Hagan M.M., Rushing P.A., Blake K.A., Yagaloff K.A., Kurylko G., Franco L., Danhoo W., and Seeley R.J. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J. Neurosci. 20 (2000) 3442-3448
3. Bhattacharyya S., Luan J., Farooqi I.S., Keogh J., Montague C., Brennand J., Jorde L., Wareham N.J., and O'Rahilly S. Studies of the neuromedin u-2 receptor gene in human obesity: evidence for the existence of two ancestral forms of the receptor. J. Endocrinol. 183 (2004) 115-120
4. Blevins J.E., Schwartz M.W., and Baskin D.G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R87-R96
5. Brown D.R., and Quito F.L. Neuromedin u octapeptide alters ion transport in porcine jejunum. Eur. J. Pharmacol. 155 (1988) 159-162
6. Chu C., Jin Q., Kunitake T., Kato K., Nabekura T., Nakazato M., Kangawa K., and Kannan H. Cardiovascular actions of central neuromedin u in conscious rats. Regul. Pept. 105 (2002) 29-34
7. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.M., Basdevant A., Bougneres P., Lebouc Y., Froguel P., and Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998) 398-401
8. Elias C.F., Lee C., Kelly J., Aschkenasi C., Ahima R.S., Couceyro P.R., Kuhar M.J., Saper C.B., and Elmquist J.K. Leptin activates hypothalamic cart neurons projecting to the spinal cord. Neuron 21 (1998) 1375-1385
9. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997) 165-168
10. Gardiner S.M., Compton A.M., Bennett T., Domin J., and Bloom S.R. Regional hemodynamic effects of neuromedin u in conscious rats. Am. J. Physiol. 258 (1990) R32-R38
11. Goke R., Fehmann H.C., Linn T., Schmidt H., Krause M., Eng J., and Goke B. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 268 (1993) 19650-19655
12. Hanada R., Nakazato M., Murakami N., Sakihara S., Yoshimatsu H., Toshinai K., Hanada T., Suda T., Kangawa K., Matsukura S., and Sakata T. A role for neuromedin u in stress response. Biochem. Biophys. Res. Commun. 289 (2001) 225-228
13. Hanada R., Teranishi H., Pearson J.T., Kurokawa M., Hosoda H., Fukushima N., Fukue Y., Serino R., Fujihara H., Ueta Y., Ikawa M., Okabe M., Murakami N., Shirai M., Yoshimatsu H., Kangawa K., and Kojima M. Neuromedin u has a novel anorexigenic effect independent of the leptin signaling pathway. Nat. Med. 10 (2004) 1067-1073
14. Howard A.D., Wang R., Pong S.S., Mellin T.N., Strack A., Guan X.M., Zeng Z., Williams Jr. D.L., Feighner S.D., Nunes C.N., Murphy B., Stair J.N., Yu H., Jiang Q., Clements M.K., Tan C.P., McKee K.K., Hreniuk D.L., McDonald T.P., Lynch K.R., Evans J.F., Austin C.P., Caskey C.T., Van der Ploeg L.H., and Liu Q. Identification of receptors for neuromedin u and its role in feeding. Nature 406 (2000) 70-74
15. Hoybye C. Endocrine and metabolic aspects of adult prader-willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm. IGF Res. 14 (2004) 1-15
16. Ivanov T.R., Lawrence C.B., Stanley P.J., and Luckman S.M. Evaluation of neuromedin u actions in energy homeostasis and pituitary function. Endocrinology 143 (2002) 3813-3821
17. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48 (1996) 413-463
18. Kojima M., Haruno R., Nakazato M., Date Y., Murakami N., Hanada R., Matsuo H., and Kangawa K. Purification and identification of neuromedin u as an endogenous ligand for an orphan receptor gpr66 (fm3). Biochem. Biophys. Res. Commun. 276 (2000) 435-438
19. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., and Hastrup S. Hypothalamic cart is a new anorectic peptide regulated by leptin. Nature 393 (1998) 72-76
20. Li X., and Hu Y. Gene expression profiling reveals the mechanism of action of anticonvulsant drug qys. Brain Res. Bull. 66 (2005) 99-105
21. Minamino N., Kangawa K., and Matsuo H. Neuromedin u-8 and u-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 130 (1985) 1078-1085
22. Morimoto I., Yamamoto S., Kai K., Fujihira T., Morita E., and Eto S. Centrally administered murine-leptin stimulates the hypothalamus-pituitary-adrenal axis through arginine-vasopressin. Neuroendocrinology 71 (2000) 366-374
23. Niimi M., Murao K., and Taminato T. Central administration of neuromedin u activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16 (2001) 201-206
24. Ozaki Y., Onaka T., Nakazato M., Saito J., Kanemoto K., Matsumoto T., and Ueta Y. Centrally administered neuromedin u activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 143 (2002) 4320-4329
25. Raddatz R., Wilson A.E., Artymyshyn R., Bonini J.A., Borowsky B., Boteju L.W., Zhou S., Kouranova E.V., Nagorny R., Guevarra M.S., Dai M., Lerman G.S., Vaysse P.J., Branchek T.A., Gerald C., Forray C., and Adham N. Identification and characterization of two neuromedin u receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 275 (2000) 32452-32459
26. Swaab D.F., Purba J.S., and Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in prader-willi syndrome: A study of five cases. J. Clin. Endocrinol. Metab. 80 (1995) 573-579
27. Tache Y., and Yang H. Brain regulation of gastric acid secretion by peptides. Sites and mechanisms of action. Ann. N. Y. Acad. Sci. 597 (1990) 128-145
28. Thorens B., Porret A., Buhler L., Deng S.P., Morel P., and Widmann C. Cloning and functional expression of the human islet glp-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42 (1993) 1678-1682
29. Vaisse C., Clement K., Guy-Grand B., and Froguel P. A frameshift mutation in human mc4r is associated with a dominant form of obesity. Nat. Genet. 20 (1998) 113-114
30. Vicennati V., Ceroni L., Gagliardi L., Pagotto U., Gambineri A., Genghini S., and Pasquali R. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. J. Endocrinol. Invest. 27 (2004) 541-547
31. Watts V.J., Lawler C.P., Gilmore J.H., Southerland S.B., Nichols D.E., and Mailman R.B. Dopamine d1 receptors: efficacy of full (dihydrexidine) vs. partial (skf38393) agonists in primates vs. rodents. Eur. J. Pharmacol. 242 (1993) 165-172
32. Yokota M., Ozaki Y., Sakamoto F., Yamada S., Saito J., Fujihara H., and Ueta Y. Fos expression in crf-containing neurons in the rat paraventricular nucleus after central administration of neuromedin u. Stress 7 (2004) 109-112
33. Zheng X., Hu Y., Liu J., and Ouyang K. Screening of active compounds as neuromedin u2 receptor agonist from natural products. Bioorg. Med. Chem. Lett. 15 (2005) 4531-4535